Citations (20)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Michiel Langeslag & Michaela Kress. (2020) The ceramide-S1P pathway as a druggable target to alleviate peripheral neuropathic pain. Expert Opinion on Therapeutic Targets 24:9, pages 869-884.
Read now
Read now
Ranjeet Prasad Dash, Rana Rais & Nuggehally R. Srinivas. (2018) Ponesimod, a selective sphingosine 1-phosphate (S1P1) receptor modulator for autoimmune diseases: review of clinical pharmacokinetics and drug disposition. Xenobiotica 48:5, pages 442-451.
Read now
Read now
Alberto Gajofatto & Marco Turatti. (2018) Investigational immunosuppressants in early-stage clinical trials for the treatment of multiple sclerosis. Expert Opinion on Investigational Drugs 27:3, pages 273-286.
Read now
Read now
Articles from other publishers (17)
Makoto Kurano, Baasanjav Uranbileg & Yutaka Yatomi. (2023) Apolipoprotein M bound sphingosine 1-phosphate suppresses NETosis through activating S1P1 and S1P4. Biomedicine & Pharmacotherapy 166, pages 115400.
Crossref
Crossref
Bao Q. Lam, Rashmi Srivastava, Jason Morvant, Sharmila Shankar & Rakesh K. Srivastava. (2021) Association of Diabetes Mellitus and Alcohol Abuse with Cancer: Molecular Mechanisms and Clinical Significance. Cells 10:11, pages 3077.
Crossref
Crossref
Hui Liu, Zonghua Luo, Jiwei Gu, Hao Jiang, Sumit Joshi, Kooresh I. Shoghi, Yun Zhou, Robert J. Gropler, Tammie L. S. Benzinger & Zhude Tu. (2020) In vivo Characterization of Four 18F-Labeled S1PR1 Tracers for Neuroinflammation. Molecular Imaging and Biology 22:5, pages 1362-1369.
Crossref
Crossref
Zili Xiao, Michael G. Yang, T. G. Murali Dhar, Hai-Yun Xiao, John L. Gilmore, David Marcoux, Kim W. McIntyre, Tracy L. Taylor, Hong Shi, Paul C. Levesque, Anthony M. Marino, Georgia Cornelius, Arvind Mathur, Ding Ren Shen, Mary Ellen Cvijic, Lois D. Lehman-McKeeman, Huadong Sun, Jenny H. Xie, Percy H. Carter & Alaric J. Dyckman. (2020)
Aryl Ether-Derived Sphingosine-1-Phosphate Receptor (S1P
1
) Modulators: Optimization of the PK, PD, and Safety Profiles
. ACS Medicinal Chemistry Letters 11:9, pages 1766-1772.
Crossref
Crossref
Élise Pépin, Tim Jalinier, Guillaume L. Lemieux, Guy Massicotte & Michel Cyr. (2020) Sphingosine-1-Phosphate Receptors Modulators Decrease Signs of Neuroinflammation and Prevent Parkinson’s Disease Symptoms in the 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Mouse Model. Frontiers in Pharmacology 11.
Crossref
Crossref
Amy Botta, Ying Liu, Sivaporn Wannaiampikul, Rungsunn Tungtrongchitr, Keith Dadson, Tae-Sik Park & Gary Sweeney. (2019) An adiponectin-S1P axis protects against lipid induced insulin resistance and cardiomyocyte cell death via reduction of oxidative stress. Nutrition & Metabolism 16:1.
Crossref
Crossref
Chiara Sassoli, Federica Pierucci, Sandra Zecchi-Orlandini & Elisabetta Meacci. (2019) Sphingosine 1-Phosphate (S1P)/ S1P Receptor Signaling and Mechanotransduction: Implications for Intrinsic Tissue Repair/Regeneration. International Journal of Molecular Sciences 20:22, pages 5545.
Crossref
Crossref
Junfei Jin, Zhongyang Lu, Yanchun Li, Ji Hyun Ru, Maria F Lopes-Virella & Yan Huang. (2018) LPS and palmitate synergistically stimulate sphingosine kinase 1 and increase sphingosine 1 phosphate in RAW264.7 macrophages. Journal of Leukocyte Biology 104:4, pages 843-853.
Crossref
Crossref
Zhijing Zhao, Junfeng Ma, Baoquan Hu, Yi Zhang & Shushu Wang. (2018) SPHK1 promotes metastasis of thyroid carcinoma through activation of the S1P/S1PR3/Notch signaling pathway. Experimental and Therapeutic Medicine.
Crossref
Crossref
Ranjeet Prasad Dash, Nuggehally R. Srinivas & Rana Rais. (2017) A review of bioanalytical quantitative methods for selected sphingosine 1‐phosphate receptor modulators. Biomedical Chromatography 32:1.
Crossref
Crossref
Haruto Kurata, Kensuke Kusumi, Kazuhiro Otsuki, Ryo Suzuki, Masakuni Kurono, Takaki Komiya, Hiroshi Hagiya, Hirotaka Mizuno, Hiroki Shioya, Takeji Ono, Yuka Takada, Tatsuo Maeda, Norikazu Matsunaga, Tetsu Kondo, Sachiko Tominaga, Ken-ici Nunoya, Hidekazu Kiyoshi, Masaharu Komeno, Shinji Nakade & Hiromu Habashita. (2017)
Discovery of a 1-Methyl-3,4-dihydronaphthalene-Based Sphingosine-1-Phosphate (S1P) Receptor Agonist Ceralifimod (ONO-4641). A S1P
1
and S1P
5
Selective Agonist for the Treatment of Autoimmune Diseases
. Journal of Medicinal Chemistry 60:23, pages 9508-9530.
Crossref
Crossref
Giancarlo Comi, Hans-Peter Hartung, Rajesh Bakshi, Ian M. Williams & Heinz Wiendl. (2017) Benefit–Risk Profile of Sphingosine-1-Phosphate Receptor Modulators in Relapsing and Secondary Progressive Multiple Sclerosis. Drugs 77:16, pages 1755-1768.
Crossref
Crossref
Ambra Vestri, Federica Pierucci, Alessia Frati, Lucia Monaco & Elisabetta Meacci. (2017) Sphingosine 1-Phosphate Receptors: Do They Have a Therapeutic Potential in Cardiac Fibrosis?. Frontiers in Pharmacology 8.
Crossref
Crossref
Ole Haagen Nielsen, Yuan Li, Bengt Johansson-Lindbom & Mehmet Coskun. (2017) Sphingosine-1-Phosphate Signaling in Inflammatory Bowel Disease. Trends in Molecular Medicine 23:4, pages 362-374.
Crossref
Crossref
Frédéric St-Cyr Giguère, Suzanne Attiori Essis, Laure Chagniel, Marc Germain, Michel Cyr & Guy Massicotte. (2017) The sphingosine-1-phosphate receptor 1 agonist SEW2871 reduces Tau-Ser262 phosphorylation in rat hippocampal slices. Brain Research 1658, pages 51-59.
Crossref
Crossref
Linda Bendall. (2016) Extracellular molecules in hematopoietic stem cell mobilisation. International Journal of Hematology 105:2, pages 118-128.
Crossref
Crossref
Wohn-Jenn Leu, Sharada Prasanna Swain, She-Hung Chan, Jui-Ling Hsu, Shih-Ping Liu, Mei-Ling Chan, Chia-Chun Yu, Lih-Ching Hsu, Yen-Lin Chou, Wei-Ling Chang, Duen-Ren Hou & Jih-Hwa Guh. (2016) Non-immunosuppressive triazole-based small molecule induces anticancer activity against human hormone-refractory prostate cancers: the role in inhibition of PI3K/AKT/mTOR and c-Myc signaling pathways. Oncotarget 7:47, pages 76995-77009.
Crossref
Crossref